Onco-Innovations Limited (CVE:ONCO) | WebDisclosure

Basculer en Français

10154	Companies
208591	Keywords
138703	Articles
110560	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

PRESS RELEASE

published on 07/12/2025 at 00:00, 8 months 21 days ago

Onco-Innovations Signs Agreement with Redwood AI to Advance Discovery and Evaluation of Its PNKP Inhibitor Technology
Onco-Innovations partners with Redwood AI for drug development, leveraging AI-driven chemistry tools to enhance cancer therapy with PNKP Compound. Vancouver-based collaboration aims to improve research efficiency

Cancer Therapy Onco-Innovations PNKP Compound Redwood AI AI-driven Chemistry
BRIEF

published on 07/11/2025 at 00:05, 8 months 22 days ago

Onco-Innovations nomme le Dr Islam Mohamed à la présidence de son conseil consultatif

Biotechnologie Conseil Consultatif Oncologie Recherche Sur Le Cancer Dr Islam Mohamed
BRIEF

published on 07/11/2025 at 00:05, 8 months 22 days ago

Onco-Innovations Appoints Dr. Islam Mohamed as Advisory Board Chair

Biotechnology Advisory Board Oncology Cancer Research Dr. Islam Mohamed
PRESS RELEASE

published on 07/11/2025 at 00:00, 8 months 22 days ago

Onco-Innovations Strengthens Clinical Leadership with Appointment of Dr. Islam Mohamed as Advisory Board Chair
Onco-Innovations Limited appoints Dr. Islam Mohamed as Chair of Scientific and Clinical Advisory Board, highlighting commitment to oncology research excellence and innovation acceleration

Scientific Advisory Board Oncology Research Onco-Innovations Limited Dr. Islam Mohamed Clinical Advisory Board
BRIEF

published on 07/05/2025 at 00:05, 8 months 28 days ago

Onco-Innovations s'associe à Nucro-Technics pour des études précliniques

Traitement Du Cancer Etudes Précliniques Onco-Innovations Nucro-Techniques Inhibiteur De La PNKP
BRIEF

published on 07/05/2025 at 00:05, 8 months 28 days ago

Onco-Innovations Partners with Nucro-Technics for Preclinical Studies

Cancer Treatment Preclinical Studies Onco-Innovations PNKP Inhibitor Nucro-Technics
PRESS RELEASE

published on 07/05/2025 at 00:00, 8 months 28 days ago

Onco-Innovations Enters Agreement with Nucro-Technics for IND-Enabling Studies, Taking a Key Step Toward Human Trials
Onco-Innovations partners with Nucro-Technics for preclinical studies on PNKP inhibitor, critical step towards human trials. Strategic collaboration with GLP and GMP experienced CRO

Clinical Trials Preclinical Studies Onco-Innovations PNKP Inhibitor Nucro-Technics
BRIEF

published on 07/03/2025 at 00:35, 8 months 30 days ago

Onco-Innovations dévoile ses développements stratégiques lors d'une conférence téléphonique avec les investisseurs

Intelligence Artificielle Traitement Du Cancer Étapes Stratégiques Onco-Innovations Inhibiteur De PNKP
BRIEF

published on 07/03/2025 at 00:35, 8 months 30 days ago

Onco-Innovations Reveals Strategic Developments in Investor Call

Artificial Intelligence Cancer Treatment Strategic Milestones Onco-Innovations PNKP Inhibitor
PRESS RELEASE

published on 07/03/2025 at 00:30, 8 months 30 days ago

Onco-Innovations CEO Highlights Strategic Milestones and R&D Progress in Special Investors' Conference Call
Onco-Innovations updates strategic roadmap for cancer treatment innovation, highlighting AI partnerships and research collaborations

Cancer Treatment Strategic Roadmap AI Partnerships Onco-Innovations Research Collaborations

Accesswire

Published on 04/02/2026 at 18:32, 2 hours 1 minute ago

Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 5 hours 33 minutes ago

Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 5 hours 53 minutes ago

Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 6 hours 3 minutes ago

Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution
Published on 04/02/2026 at 14:10, 6 hours 23 minutes ago

Side-by-Side Conference Hosts Close to 800 Participants in Malta to Advance Women's Health Care

View all ACCESSWIRE

EQS Group

Published on 04/02/2026 at 19:52, 40 minutes ago

E-PANGO: Composition du capital au 31 mars 2026
Published on 04/02/2026 at 19:00, 1 hour 32 minutes ago

PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 04/02/2026 at 18:35, 1 hour 57 minutes ago

daydream Raises $15M Series A to Build the World's Best AI-Native Agency for SEO
Published on 04/02/2026 at 18:30, 2 hours 2 minutes ago

Avolta Publishes Invitation to its Annual General Meeting 2026
Published on 04/02/2026 at 18:30, 2 hours 2 minutes ago

Forbo shareholders approved all proposals of the Board of Directors

Les Echos

Published on 04/02/2026 at 18:39, 1 hour 53 minutes ago

Mersen: Disclosure of trading own shares
Published on 04/02/2026 at 18:39, 1 hour 53 minutes ago

Mersen : Déclaration des transactions sur actions propres
Published on 04/02/2026 at 18:30, 2 hours 3 minutes ago

Thales met à disposition son Document d’Enregistrement Universel 2025
Published on 04/02/2026 at 18:30, 2 hours 3 minutes ago

Thales makes available its Universal Registration Document 2025
Published on 04/02/2026 at 18:22, 2 hours 10 minutes ago

TF1 - Déclaration mensuelle des actions et droits de vote - Mars 2026

View all LES ECHOS COMFI WIRE